Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Fisher & Paykel Healthcare Corporation Limited ( (FSPKF) ) is now available.
Fisher & Paykel Healthcare Corporation Limited, a prominent player in the healthcare industry, is facing new challenges as the United States has announced a 10% tariff on products manufactured in New Zealand. Despite the new tariffs, the company does not expect a significant impact on its net profit for the 2025 financial year, though costs may rise in 2026. The company remains committed to reaching its gross margin target and will update stakeholders on its outlook and strategies at the end of May.
More about Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare is a leading designer, manufacturer, and marketer of products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide.
YTD Price Performance: -34.65%
Average Trading Volume: 320
Technical Sentiment Signal: Buy
Current Market Cap: $11.24B
For an in-depth examination of FSPKF stock, go to TipRanks’ Stock Analysis page.